271 related articles for article (PubMed ID: 35508083)
1. Interaction of compounds derived from the Chinese medicinal formula Huangqi Guizhi Wuwu Tang with stroke-related numbness and weakness targets: An in-silico docking and molecular dynamics study.
Lee S; Wong AR; Yang AWH; Hung A
Comput Biol Med; 2022 Jul; 146():105568. PubMed ID: 35508083
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Action of a Herbal Formula Huangqi Guizhi Wuwu Tang for the Management of Post-Stroke Related Numbness and Weakness: A Computational Molecular Docking Study.
Lee S; Hung A; Li H; Yang AWH
J Evid Based Integr Med; 2022; 27():2515690X221082989. PubMed ID: 35369720
[TBL] [Abstract][Full Text] [Related]
3. Conjugated β-Cyclodextrin Enhances the Affinity of Folic Acid towards FRα: Molecular Dynamics Study.
Al-Thiabat MG; Gazzali AM; Mohtar N; Murugaiyah V; Kamarulzaman EE; Yap BK; Rahman NA; Othman R; Wahab HA
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500740
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
[TBL] [Abstract][Full Text] [Related]
5. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
[TBL] [Abstract][Full Text] [Related]
6. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
Mishra V; Pathak C
J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
[TBL] [Abstract][Full Text] [Related]
7. Developing Hispolon-based novel anticancer therapeutics against human (NF-κβ) using
Paul M; Kumar Panda M; Thatoi H
J Biomol Struct Dyn; 2019 Sep; 37(15):3947-3967. PubMed ID: 30295165
[TBL] [Abstract][Full Text] [Related]
8. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
Thillainayagam M; Malathi K; Ramaiah S
J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266
[TBL] [Abstract][Full Text] [Related]
9. An insight into the simulation directed understanding of the mechanism in SARS CoV-2 N-CTD, dimer integrity, and RNA-binding: Identifying potential antiviral inhibitors.
Chauhan A; Avti PK; Shekhar N; Prajapat M; Sarma P; Sangwan N; Singh J; Bhattacharyya A; Kumar S; Kaur H; Sharma S; Prakash A; Medhi B
J Biomol Struct Dyn; 2022; 40(24):13912-13924. PubMed ID: 34751101
[TBL] [Abstract][Full Text] [Related]
10. A novel identification approach for discovery of 5-HydroxyTriptamine 2A antagonists: combination of 2D/3D similarity screening, molecular docking and molecular dynamics.
Kumar R; Jade D; Gupta D
J Biomol Struct Dyn; 2019 Mar; 37(4):931-943. PubMed ID: 29468945
[TBL] [Abstract][Full Text] [Related]
11. Computational analysis of natural product B-Raf inhibitors.
Chettri S; Sasmal P; Adon T; Sajeev Kumar B; Kumar BP; Raghavendra NM
J Mol Graph Model; 2023 Jan; 118():108340. PubMed ID: 36208592
[TBL] [Abstract][Full Text] [Related]
12. Identification of Helicobacter pylori-carcinogenic TNF-alpha-inducing protein inhibitors via daidzein derivatives through computational approaches.
Tayyeb JZ; Mondal S; Anisur Rahman M; Kumar S; Bayıl I; Akash S; Hossain MS; Alqahtani T; Zaki MEA; Oliveira JIN
J Cell Mol Med; 2024 May; 28(9):e18358. PubMed ID: 38693868
[TBL] [Abstract][Full Text] [Related]
13. Molecular docking and dynamics studies of 4-anilino quinazolines for epidermal growth factor receptor tyrosine kinase to find potent inhibitor.
Muthuvel SK; Elumalai E; K G; K H
J Recept Signal Transduct Res; 2018; 38(5-6):475-483. PubMed ID: 31038021
[TBL] [Abstract][Full Text] [Related]
14. Anti-Inflammatory and Anti-Rheumatic Potential of Selective Plant Compounds by Targeting TLR-4/AP-1 Signaling: A Comprehensive Molecular Docking and Simulation Approaches.
Khan A; Khan SU; Khan A; Shal B; Rehman SU; Rehman SU; Htar TT; Khan S; Anwar S; Alafnan A; Rengasamy KR
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807562
[TBL] [Abstract][Full Text] [Related]
15. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
[TBL] [Abstract][Full Text] [Related]
16. Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2:
Kumar N; Singh A; Gulati HK; Bhagat K; Kaur K; Kaur J; Dudhal S; Duggal A; Gulati P; Singh H; Singh JV; Bedi PMS
Phytomed Plus; 2021 Nov; 1(4):100083. PubMed ID: 35403086
[TBL] [Abstract][Full Text] [Related]
17. Huangqi Guizhi Wuwu decoction in peripheral neurotoxicity treatment using network pharmacology and molecular docking.
Chen T; Shi Y; Shi W
Medicine (Baltimore); 2022 Oct; 101(42):e31281. PubMed ID: 36281162
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and bioevaluation of novel unsaturated cyanoacetamide derivatives: In vitro and in silico exploration.
Uddin KM; Meem MH; Akter M; Rahman S; Al-Gawati MA; Alarifi N; Albrithen H; Alodhayb A; Poirier RA; Bhuiyan MMH
MethodsX; 2024 Jun; 12():102691. PubMed ID: 38660042
[TBL] [Abstract][Full Text] [Related]
19. Computational investigation of phytochemicals from
Omoboyowa DA; Singh G; Fatoki JO; Oyeneyin OE
J Biomol Struct Dyn; 2023; 41(12):5568-5582. PubMed ID: 35773777
[TBL] [Abstract][Full Text] [Related]
20. Research on the Mechanism of Guizhi to Treat Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking Technology.
He D; Li Q; Du G; Sun J; Meng G; Chen S
Biomed Res Int; 2021; 2021():8141075. PubMed ID: 34873575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
